NCT05203224View on ClinicalTrials.gov

Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)

PHASE2RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Ischemic Stroke
Interventions
DRUG

Dornase Alfa

Intravenous Dornase alfa

Trial Locations (3)

3050

RECRUITING

Royal Melbourne Hospital, Melbourne

4102

RECRUITING

Princess Alexandra Hospital, Brisbane

5000

NOT_YET_RECRUITING

Royal Adelaide Hospital, Adelaide

All Listed Sponsors
lead

University of Melbourne

OTHER